After gaining millions of dollars in BioNTech investments, coincidently the partner for Pfizer's mRNA vaccines, Bill Gates decreased his shares in the company by 86%.
The move would re-organize the federal handling of the virus, so it is treated as a common threat to public health that can be handled through the usual powers of agencies.
